Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer

202379 citationsJournal Articlegold Open Access

Authors

François Ghiringhelli · Inserm

Frédéric Bibeau · Université de franche-comté

Laurent Greillier · Centre National de la Recherche Scientifique

Jean-David Fumet · Inserm

Alis Ilie · Centre Georges François Leclerc

Florence Monville

Caroline Laugé

Aurélie Catteau

Abstract

Veracyte, INSERM, Labex Immuno-Oncology, Transcan ERAnet European project, ARC, SIRIC, CARPEM, Ligue Contre le Cancer, ANR, QNRF, INCa France, Louis Jeantet Prize Foundation.

Topics & Keywords

Cancer Immunotherapy and Biomarkers Bladder and Urothelial Cancer Treatments Immunotherapy and Immune Responses

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: EBioMedicine

Volume 92, pp. 104633-104633

DOI: 10.1016/j.ebiom.2023.104633

Field-Weighted Citation Impact: 19.76